RXST Stock Analysis: Buy, Sell, or Hold?
RXST - RxSight, Inc. Common Stock
$5.68
0.05 (0.89%)
▲
5d:
-2.91%
30d:
-23.04%
90d:
-29.35%
BUY
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Smart Money Accumulation
RXST is down 8.0% this week, but smart money is accumulating calls. Top strike: $10 2026-06-18 with 31 OI. Call ratio: 100% View Scanner →
Strength: 9.0/10
Get Alerted When RXST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: RXST shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: RXST shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: RXST is currently trading at $5.68, which is considered oversold relative to its 30-day fair value range of $6.10 to $7.49.
Technical Outlook: Technically, RXST is in a strong downtrend. Immediate support is located at $5.30, while resistance sits at $7.49.
Market Sentiment: RXST has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (26th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $8.79 (+54.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RXST is in a strong downtrend. Immediate support is located at $5.30, while resistance sits at $7.49.
Market Sentiment: RXST has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (26th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $8.79 (+54.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$6.10 -
$7.49
Company Quality Score
50/100
(HOLD)
Options IV Signal
26th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 26th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 54.7% below Wall St target ($8.79)
Trading Range Analysis
30-Day Trading Range
$6.10 -
$7.49
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.33
(23.4%)
Support & Resistance Levels
Support Level
$5.30
Resistance Level
$7.49
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.31
Wall Street Target
$8.79
(+54.7%)
Revenue Growth (YoY)
-18.5%
Profit Margin
-36.6%
Share & Embed Analysis
Last updated: May 18, 2026 4:58 AM ET
Data refreshes hourly during market hours. Next update: 5:58 AM
Data refreshes hourly during market hours. Next update: 5:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RXST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
